Osivax

Clinical research in influenza centers on preventive vaccines designed to reduce type A influenza illness in healthy adults. The sponsor’s studies focus on immunogenicity, efficacy, and safety in the context of seasonal respiratory infection.

• Influenza vaccine development
• Type A influenza prevention
• Respiratory viral disease protection

The work reflects interest in adult vaccination strategies and immune protection against laboratory-confirmed influenza illness.